News

GE has launched a new initiative aimed at accelerating cancer innovation and improving care for 10 million patients around the world by 2020. As part of Thursday's announcement, GE is sponsoring a $100 million open innovation challenge to identify and bring to market ideas that advance breast cancer diagnostics.

The American Medical Informatics Association argues that when it comes to oversight of clinical decision support systems, the most critical factor in determining the risk classification of different types of software is whether the CDS is mediated by a human being or not.Meryl Bloomrosen, AMIA's vice president for public policy and government relations, has offered those comments in response to the U.S. Food and Drug Administration's (FDA) invitation to participate in a public workshop related to FDA's Draft Guidance on mobile medical applications